Meta is giving Instagram users a rare glimpse into why certain posts are showing up on their Reels, the platform’s feed of algorithmically curated videos. Starting today, users will now see a list of ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

ORLANDO, Fla. — Steering clinicians toward a cascade approach for thyroid function testing cut unnecessary orders by a monthly average of 15% and concurrent orders by 19% per month, according to ...

RXRX stock looks like a deep-value growth bet at just $5 and change. Though the technology is exciting, I’m not rushing into shares just yet. Nvidia made early investors rich, but there is a new class ...

The modern internet is ruled by algorithms. When you boot up Instagram, for example, what you see in your feed is strategically sorted by the app's AI based on your past activity to keep you engaged ...

NEW YORK, July 9 (Reuters) - TikTok is preparing to launch a standalone app for U.S. users that is expected to operate on a separate algorithm and data system from its global app, laying the ...

Amsterdam’s struggles with its welfare fraud algorithm show us the stakes of deploying AI in situations that directly affect human lives. What Amsterdam’s welfare fraud algorithm taught me about fair ...

MicroAlgo Inc. announced its research on the Quantum Information Recursive Optimization (QIRO) algorithm, which aims to address complex combinatorial optimization problems using quantum computing.

The results of a recent survey released Tuesday showed President Trump's actions are likely to make it harder for biotech companies like Recursion to raise capital. The company reported ...

Evidently in the mood for some spring cleaning, Salt Lake City’s Recursion is clearing out a chunk of its pipeline as it narrows its focus on R&D in oncology and rare diseases. The move comes roughly ...